We need support and collaboration from all stakeholders to ensure that hemophiliacs can get access to health servicesJakarta (ANTARA) - Director-General of Pharmaceuticals and Medical Devices at the Ministry of Health, Lucia Rizka Andalusia, stated that the government had opened up opportunities for collaboration from various parties to treat hemophilia patients by offering optimal treatment.
"We need support and collaboration from all stakeholders to ensure that hemophiliacs can get access to health services," Andalusia noted in a speech read out by Secretary of the Directorate General of Pharmaceuticals and Medical Devices Dita Novianti Sugandi Argadiredja during a webinar, Tuesday.
She later noted that the Ministry of Health was committed to conducting transformation in the health system in order to realize a healthy, productive, and independent society.
The transformation conducted includes the transformation of primary services in public access to qualified health services. Transformation is also conducted in health financing to create sufficient and sustainable finance with fair allocation, she remarked.
Despite problems still being faced by the facilities to cure hemophilia, Argadiredja noted that there were several referral hospitals that can treat hemophilia in a multidisciplinary manner.
The Ministry of Health has issued the National Guidelines for Medical Services (PNPK) for Hemophilia Management to serve as a reference to prepare the standard operating procedures for hemophilia treatment in every health facility.
"We hope that the PNPK for Hemophilia Management would be applied throughout Indonesia, from diagnosis to treatment, including the provision of preventive prophylactic therapy," Andalusia noted.
With the implementation of these guidelines, it is expected that all patients would have equal opportunity and access to health services. In 2020, some 2,706 people were diagnosed with hemophilia, below the estimated 28 thousand patients. However, Andalusia believes that several challenges are faced in the efforts to detect hemophilia in Indonesia.
Hemophilia is a hereditary disease that interferes with the blood clotting process. The main symptom of hemophilia is non-stop bleeding that is usually more common in men.
Related news: PMI prepares gifts to garner blood donors' interest during Ramadan
Related news: Ministry readies single platform to integrate health applications
Related news: Health Ministry expresses commitment to supporting disabled people
Translator: Nanien Yuniar, Resinta S
Editor: Sri Haryati
Copyright © ANTARA 2022
